NCT00929526 - Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study | Biotech Hunter

Enrollment

752

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Infections, Papillomavirus

Interventions

PROCEDURE

Liquid-based cytology (LBC) sampling

LBC samples will be collected at Months 36 and 48 for cytology and HPV DNA testing (by PCR)

PROCEDURE

Blood sampling

Blood samples will be collected at Months 36 and 48 for antibody determination

Trial Locations (13)

GSK Investigational Site, Aomori

GSK Investigational Site, Fukui

GSK Investigational Site, Hiroshima

GSK Investigational Site, Hiroshima

GSK Investigational Site, Kagoshima

GSK Investigational Site, Kagoshima

GSK Investigational Site, Miyazaki